Clinical Trial Update: CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating CD34 selection of peripheral blood stem cell grafts for autologous transplantation in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Stanford University | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED